ABSTRACT
No disponible
Subject(s)
Humans , Female , Middle Aged , Aged , Estrogen Replacement Therapy/adverse effects , Breast Neoplasms/etiologyABSTRACT
No disponible
Subject(s)
Humans , Male , Female , Pregnancy , Prenatal Diagnosis/methods , Genetic Testing/methods , Neonatal Screening/methods , Genetic Diseases, Inborn/diagnosis , Amniocentesis/methods , Chorionic Villi Sampling/methods , Practice Patterns, Physicians'ABSTRACT
No disponible
Subject(s)
Humans , Female , Urinary Bladder, Overactive/diagnosis , Urinary Incontinence, Stress/diagnosis , Diagnosis, Differential , Urinary Bladder, Overactive/therapy , Urinary Incontinence, Stress/therapy , Urinary Tract Infections/diagnosis , Risk FactorsABSTRACT
No disponible
Subject(s)
Humans , Insemination, Artificial, Heterologous/methods , Pregnancy Rate , Cryopreservation/methods , Ovulation Induction/methods , Societies, Medical/statistics & numerical data , Semen , Dilution/methods , Infertility, Female/diagnosisABSTRACT
No disponible
Subject(s)
Humans , Male , Female , Ovulation Induction/methods , Fertilization in Vitro/methods , Spermatozoa , Gonadotropins/therapeutic use , Follicle Stimulating Hormone/therapeutic use , Contraceptives, Oral/therapeutic use , Inositol/therapeutic use , Metformin/therapeutic use , In Vitro Oocyte Maturation TechniquesABSTRACT
No disponible
Subject(s)
Humans , Candidiasis, Vulvovaginal/diagnosis , Candidiasis, Vulvovaginal/therapy , Infections/epidemiology , Microbiota/physiology , Mycoses/epidemiology , Vaginosis, Bacterial/diagnosis , Vaginosis, Bacterial/therapy , Genital Diseases, Female/diagnosis , Genital Diseases, Female/therapy , Medical History Taking/statistics & numerical dataABSTRACT
No disponible
Subject(s)
Female , Humans , Version, Fetal/instrumentation , Version, Fetal/methods , Version, Fetal , Obstetric Surgical Procedures/methods , Analgesia/methods , Analgesia , Version, Fetal/ethics , Version, Fetal/standards , Version, FetalABSTRACT
OBJETIVO: El principal objetivo que debemos perseguir en una mujer gestante con infección por el VIH es la prevención de la transmisión vertical (TV); por ello, es fundamental realizar tratamiento antirretroviral (TAR) en todas ellas, independientemente del número de linfocitos CD4 que tengan. Es obligatorio ofrecer a toda embarazada la información adecuada y la realización de la serología frente al virus de la inmunodeficiencia humana (VIH) en la primera visita. Métodos Se reunió a un panel de expertos designados por la Secretaría del Plan Nacional sobre el Sida (SPNS) y las diferentes sociedades científicas participantes, que incluyó médicos especialistas en medicina interna con experiencia en el ámbito del VIH, ginecólogos/as y pediatras y psicólogos, actuando 4 miembros del panel como coordinadores. Se revisó información científica hasta noviembre de 2012. Como apoyo a las recomendaciones se utilizaron 2 niveles de evidencia: la fuerza de la recomendación según opinión del experto (A, B, C) y el nivel de evidencia empírica (I, II, III), ambos niveles basados en los criterios de la Infectious Disease Society of America, ya utilizada en documentos previos de la SPNS. Resultados y conclusiones Este documento pretende revisar los conocimientos científicos actuales y, en función de ello, elaborar una serie de recomendaciones con respecto al TAR, tanto desde el punto de vista de la salud individual de la madre como con el objetivo de minimizar en lo posible el riesgo de TV, atendiendo, además, a otros cuidados de salud de la embarazada con infección por el VIH. Se discuten y evalúan, asimismo, otras estrategias capaces
OBJECTIVE: The main objective in the management of HIV-infected pregnant women is prevention of mother-to-child transmission; therefore, it is essential to provide universal antiretroviral treatment, regardless of CD4 count. All pregnant women must receive adequate information and undergo HIV serology testing at the first visit. METHODS: We assembled a panel of experts appointed by the Secretariat of the National AIDS Plan (SPNS) and the other participating Scientific Societies, which included internal medicine physicians with expetise in the field of HIV infection, gynecologists, pediatricians and psychologists. Four panel members acted as coordinators. Scientific information was reviewed in publications and conference reports up to November 2012. In keeping with the criteria of the Infectious Diseases Society of America, 2 levels of evidence were applied to support the proposed recommendations: the strength of the recommendation according to expert opinion (A, B, C), and the level of empirical evidence (I, II, III). This approach has already been used in previous documents from SPNS. RESULTS AND CONCLUSIONS: The aim of this paper was to review current scientific knowledge, and, accordingly, develop a set of recommendations regarding antiretroviral therapy (ART), regarding the health of the mother, and from the perspective of minimizing mother-to-child transmission (MTCT), also taking into account the rest of the health care of pregnant women with HIV infection. We also discuss and evaluate other strategies to reduce the MTCT (elective Cesarean, child's treatment ), and different aspects of the topic (ARV regimens, their toxicity, monitoring during pregnancy and postpartum, etc.)
Subject(s)
Humans , Female , Pregnancy , HIV Infections/epidemiology , Pregnancy Complications, Infectious/drug therapy , Antiretroviral Therapy, Highly Active , Anti-Retroviral Agents/therapeutic use , HIV Infections/transmission , Infectious Disease Transmission, Vertical/prevention & control , Obstetric Labor Complications , HIV/pathogenicity , Practice Patterns, Physicians'ABSTRACT
Protocolo de diagnóstico prenatal de los defectos congénitos y cribado de las anomalías cromosómicas. Forma parte de los Protocolos y Guías de Actuación Clínica en Ginecología y Obstetricia promovidos por la Sociedad Española de Ginecología y Obstetricia (SEGO) y ha sido actualizado en noviembre del 2010. Disponible en la web de la sociedad referida (www.prosego.es)(AU)
This protocol for prenatal diagnosis of birth defects and screening for chromosomal abnormalities is part of the Protocols and Guidelines of Clinical Practice in Gynaecology and Obstetrics sponsored by the Spanish Society of Gynaecology and Obstetrics (SEGO). Updated in November 2010. It is available on the website of the aforementioned society (www.prosego.es)(AU)
Subject(s)
Humans , Male , Female , Congenital Abnormalities/epidemiology , Congenital Abnormalities/prevention & control , Aneuploidy , Minimally Invasive Surgical Procedures/methods , Minimally Invasive Surgical Procedures , Prenatal Diagnosis/methods , Prenatal Diagnosis/trends , Prenatal Diagnosis , Congenital Abnormalities/diagnosis , Mass Screening/methods , Down Syndrome/complications , Down SyndromeABSTRACT
No disponible
Subject(s)
Humans , Female , Perinatal Care/methods , Perinatal Care , Infections/complications , Infections/diagnosis , Infectious Disease Transmission, Vertical/prevention & control , Infectious Disease Transmission, Vertical/statistics & numerical data , Streptococcus agalactiae/isolation & purification , Streptococcus agalactiae/pathogenicity , Cohort Studies , Chorioamnionitis/diagnosis , Antibiotic Prophylaxis , Post-Exposure ProphylaxisABSTRACT
El personal sanitario se encuentra incluido cada año entre los grupos de riesgo con indicación para vacunarse frente a la gripe. No obstante, las coberturas vacunales entre el personal sanitario en nuestro país son muy bajas no superando el 25%.Convencidos de que una de las mejores herramientas para aumentar estas coberturas entre los profesionales de nuestro país son las evidencias científicas, 19 Sociedades Científicas y Asociaciones Profesionales que agrupan a los profesionales sanitarios más directamente relacionados con la gripe como problema de salud, así como el Consejo General de Enfermería, se han reunido para debatir y elaborar este documento de consenso con el objetivo de concienciar al personal sanitario sobre la conveniencia de su vacunación frente a la gripe y de los beneficios que de ella se derivan para sí mismos, para sus pacientes y para el resto de la población. Esta recomendación está basada en 3 pilares básicos: argumento de necesidad, de ética y de ejemplaridad(AU)
Health care workers (HCW) are included each year among risk groups for vaccination against influenza. However, vaccination coverage among this group in our country is very low, not exceeding 25%. Convinced that one of the best tools to increase this coverage among professionals in our country are the scientific evidence, 19 scientific societies and associations professionals bringing together health professionals more directly related to influenza as an health problem, and the General Nursing Council, met to discuss and develop this consensus document in order to inform HCW about the appropriateness of their vaccination against influenza and the benefits that flow from it for themselves, for their patients and for the rest of the population. This recommendation is based on 3 pillars: argument of necessity, ethics and exemplary(AU)
Subject(s)
Humans , Male , Female , Mass Vaccination/methods , 51352 , Health Personnel/standards , Health Personnel/trends , Influenza Vaccines/administration & dosage , Influenza Vaccines/therapeutic use , Influenza, Human/immunology , /immunology , Risk Groups , Societies, Scientific/ethics , Societies, Scientific/standards , Evaluation of the Efficacy-Effectiveness of InterventionsABSTRACT
No disponible
Subject(s)
Female , Humans , Male , Pregnancy , Clinical Protocols/classification , Fertilization/genetics , Delivery of Health Care, Integrated/ethics , Delivery of Health Care, Integrated/methods , Pregnant Women/psychology , Reproductive Health/education , Clinical Protocols/standards , Fertilization/physiology , Delivery of Health Care, Integrated , Delivery of Health Care, Integrated/standards , Pregnant Women/ethnology , Reproductive Health/trendsABSTRACT
No disponible
Subject(s)
Female , Humans , Pregnancy , Abortion, Spontaneous/genetics , Abortion, Spontaneous/metabolism , Hemorrhage/blood , Hemorrhage/genetics , Medical History Taking/methods , Pregnancy, Ectopic/genetics , Pregnancy, Ectopic/pathology , Hematometra/blood , Hematometra/embryology , Uterine Hemorrhage/blood , Abortion, Spontaneous/rehabilitation , Abortion, Spontaneous/therapy , Hemorrhage/complications , Hemorrhage/pathology , Medical History Taking/standards , Pregnancy, Ectopic/diagnosis , Pregnancy, Ectopic/metabolism , Hematometra/metabolism , Hematometra/pathology , Uterine Hemorrhage/embryologyABSTRACT
No disponible
No disponible
